BridgeBio Pharma, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of BBIO for the last quarter is 211.12 M USD, and it's 11998.57% higher compared to the previous quarter. The net income of Q1 24 is -35.22 M USD.